<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To select autoantibody signatures for early detection of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>EXPERIMENTAL DESIGN: A phage cDNA expression library was constructed with fresh <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> from 30 CRC patients and biopanned by using serum pools of 20 CRC patients and 20 healthy controls </plain></SENT>
<SENT sid="2" pm="."><plain>A classifier was discovered in the training set of 30 CRC patients at stages I and II and 30 matched healthy controls and then blindly validated in an independent set of 60 CRC patients, 60 healthy controls, 52 <z:mpath ids='MPATH_491'>polyps</z:mpath> patients, and 30 <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> patients </plain></SENT>
<SENT sid="3" pm="."><plain>Expression of proteins was examined by using immunohistochemistry </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Five-phage <z:chebi fb="7" ids="16670">peptide</z:chebi> clones showing higher discriminatory power than others in training set were selected for validation </plain></SENT>
<SENT sid="5" pm="."><plain>The five-phage <z:chebi fb="7" ids="16670">peptide</z:chebi> classifier was able to discriminate between early <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients and healthy controls, with sensitivities of 90.0% to 92.7% and specificities of 91.7% to 93.3% </plain></SENT>
<SENT sid="6" pm="."><plain>In those with serum carcinoembryonic antigen less than 5 ng/mL, the classifier was efficient in discriminating <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> from healthy controls, with an area under the curve of 0.975 </plain></SENT>
<SENT sid="7" pm="."><plain>The classifier was able to discriminate <z:hpo ids='HP_0000001'>all</z:hpo> of the 9 patients with serrated <z:mpath ids='MPATH_270'>adenoma</z:mpath> from healthy controls </plain></SENT>
<SENT sid="8" pm="."><plain>Thirteen (43.3%) of the patients with <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> were misclassified </plain></SENT>
<SENT sid="9" pm="."><plain>Of the five phage <z:chebi fb="7" ids="16670">peptides</z:chebi>, one encoded a <z:chebi fb="7" ids="16670">peptide</z:chebi> identical to immunoglobulin G (IgG) heavy-chain constant region </plain></SENT>
<SENT sid="10" pm="."><plain>IgG immunostaining was stronger in mesenchymal cells than in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and was apparent in serrated <z:mpath ids='MPATH_270'>adenoma</z:mpath> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: The five-phage <z:chebi fb="7" ids="16670">peptide</z:chebi> classifier stands out as promising early diagnostic biomarkers for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, but it is unsuitable for discriminating <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> from <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Truncated IgGs generated from the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> might be novel <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>-associated antigens </plain></SENT>
</text></document>